This scientific commentary refers to 'Safety and biomarker effects of candesartan in non-hypertensive adults with prodromal Alzheimer's disease' by Hajjar et al. (https://doi.org/10.1093/braincomms/fcac270).
© The Author(s) 2022. Published by Oxford University Press on behalf of the Guarantors of Brain.